Keratitis, ichthyosis, and deafness (KID) syndrome: management with chronic oral ketoconazole therapy.
Extensive cutaneous mycoses have been described in patients with the keratitis, ichthyosis, and deafness (KID) syndrome. We present a case occurring in a 48-year-old woman where improvement in the ichthyosiform dermatosis, stabilization of her ocular disease, and apparent partial prevention of further cutaneous malignancies occurred in association with ketoconazole therapy.
Hazen
P G
PG
Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Walker
A E
AE
Stewart
J J
JJ
Carney
J F
JF
Engstrom
C W
CW
Turgeon
K L
KL
D000284:Administration, Oral; D000328:Adult; D002179:Candidiasis, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D005260:Female; D005534:Foot Diseases / Q000473:pathology; D034381:Hearing Loss / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007057:Ichthyosis / Q000188:drug therapy* / Q000473:pathology; D007634:Keratitis / Q000188:drug therapy* / Q000473:pathology; D007654:Ketoconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D013577:Syndrome; D014005:Tinea / Q000188:drug therapy* / Q000473:pathology
D007654:Ketoconazole